Combination chemotherapy-radiotherapy for stage 3 Hodgkin's disease. An acute leukemia group B study.
D000328:Adult; D000367:Age Factors; D001772:Blood Cell Count; D001792:Blood Platelets; D001853:Bone Marrow / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005260:Female; D006452:Hemoglobinometry; D006689:Hodgkin Disease / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009188:Myelitis, Transverse / Q000139:chemically induced; D010538:Peritonitis / Q000139:chemically induced; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D011879:Radiotherapy Dosage; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008466:Mechlorethamine; D014747:Vinblastine